SU 4312;3-[[4-(dimethylamino)phenyl]methylene]-1,3-dihydro-2H-indol-2-one;3-(4-Dimethylaminobenzylidenyl)-2-indolinone;3-[[(4-Dimethylamino)phenyl]methylene]-1,3-dihydro-2H-indol-2-one, E/Z mixture;SU4312;Su 4312;3-[[4-(dimethylamino)phenyl]methylene]-1,3-dihydro-2h-indol-2-one
SU4312 is the racemate of (Z)-SU4312 and (E)-SU4312. (Z)-SU4312 inhibits PDGFR and FLK-1 with IC 50 s of 19.4 and 0.8 μM, respectively. (E)-SU4312 inhibits PDGFR, FLK-1, EGFR, HER-2, and IGF-1R with IC 50 s of 24.2, 5.2, 18.5, 16.9 and 10.0 μM, respectively.
性状
Solid
IC50 & Target[1][2]
PDGFR Flk-1
体外研究(In Vitro)
Receptor tyrosine kinases (RTKs) have been shown to be important mediators of cellular signal transduction in cells. Many RTKs have been shown to be oncogene products implicating their role in the transformation process associated with human cancers. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. L Sun, et al. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J Med Chem. 1998 Jul 2;41(14):2588-603.
溶解度数据
In Vitro: DMSO : 50 mg/mL (189.16 mM; Need ultrasonic)配制储备液